272 related articles for article (PubMed ID: 28346226)
1. A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens.
Sindhava VJ; Oropallo MA; Moody K; Naradikian M; Higdon LE; Zhou L; Myles A; Green N; Nündel K; Stohl W; Schmidt AM; Cao W; Dorta-Estremera S; Kambayashi T; Marshak-Rothstein A; Cancro MP
J Clin Invest; 2017 May; 127(5):1651-1663. PubMed ID: 28346226
[TBL] [Abstract][Full Text] [Related]
2. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
3. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
4. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
5. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens.
Chaturvedi A; Dorward D; Pierce SK
Immunity; 2008 Jun; 28(6):799-809. PubMed ID: 18513998
[TBL] [Abstract][Full Text] [Related]
6. T-bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades.
Kövesdi D; Angyal A; Huber K; Szili D; Sármay G
Eur J Immunol; 2014 Mar; 44(3):887-93. PubMed ID: 24249581
[TBL] [Abstract][Full Text] [Related]
7. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
8. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
[TBL] [Abstract][Full Text] [Related]
9. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
[TBL] [Abstract][Full Text] [Related]
10. TLR9-mediated signals rescue B-cells from Fas-induced apoptosis via inactivation of caspases.
Hancz A; Koncz G; Szili D; Sármay G
Immunol Lett; 2012 Mar; 143(1):77-84. PubMed ID: 22553782
[TBL] [Abstract][Full Text] [Related]
11. BCR-mediated uptake of antigen linked to TLR9 ligand stimulates B-cell proliferation and antigen-specific plasma cell formation.
Eckl-Dorna J; Batista FD
Blood; 2009 Apr; 113(17):3969-77. PubMed ID: 19144984
[TBL] [Abstract][Full Text] [Related]
12. Plasmodium DNA-mediated TLR9 activation of T-bet
Rivera-Correa J; Guthmiller JJ; Vijay R; Fernandez-Arias C; Pardo-Ruge MA; Gonzalez S; Butler NS; Rodriguez A
Nat Commun; 2017 Nov; 8(1):1282. PubMed ID: 29101363
[TBL] [Abstract][Full Text] [Related]
13. TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.
Szili D; Bankó Z; Tóth EA; Nagy G; Rojkovich B; Gáti T; Simon M; Hérincs Z; Sármay G
PLoS One; 2014; 9(5):e96381. PubMed ID: 24801688
[TBL] [Abstract][Full Text] [Related]
14. CMTM7 plays key roles in TLR-induced plasma cell differentiation and p38 activation in murine B-1 B cells.
Liu Z; Liu Y; Li T; Wang P; Mo X; Lv P; Ma D; Han W
Eur J Immunol; 2020 Jun; 50(6):809-821. PubMed ID: 32022930
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 and interferon-γ receptor signaling suppress the B-cell fate of uncommitted progenitors in mice.
Baratono SR; Chu N; Richman LP; Behrens EM
Eur J Immunol; 2015 May; 45(5):1313-25. PubMed ID: 25639361
[TBL] [Abstract][Full Text] [Related]
17. Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.
Naradikian MS; Myles A; Beiting DP; Roberts KJ; Dawson L; Herati RS; Bengsch B; Linderman SL; Stelekati E; Spolski R; Wherry EJ; Hunter C; Hensley SE; Leonard WJ; Cancro MP
J Immunol; 2016 Aug; 197(4):1023-8. PubMed ID: 27430719
[TBL] [Abstract][Full Text] [Related]
18. CD11c
Levack RC; Newell KL; Popescu M; Cabrera-Martinez B; Winslow GM
J Immunol; 2020 Aug; 205(4):1050-1058. PubMed ID: 32680956
[TBL] [Abstract][Full Text] [Related]
19. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
Liu N; Ohnishi N; Ni L; Akira S; Bacon KB
Nat Immunol; 2003 Jul; 4(7):687-93. PubMed ID: 12766768
[TBL] [Abstract][Full Text] [Related]
20. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation.
Thomas M; Calamito M; Srivastava B; Maillard I; Pear WS; Allman D
Blood; 2007 Apr; 109(8):3342-50. PubMed ID: 17179224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
